Summary
Acid phospholipase A1 activity in liver (rat, human) is predominantly localized in lysosomes. A minor proportion (less than 3% of the total activity) is also present in the Golgi apparatus and the endoplasmic reticulum, presumably due to enzymatically active precursors of the corresponding lysosomal enzyme. Lysosomal phospholipase A1 is the most important enzyme initiating the intralysosomal catabolism of diacylphosphoglycerides. It has been purified 50,600-fold, with a yield of about 26%. The enzyme prefers phosphatidylethanolamine as a substrate, which at 200 µM and pH 4.5, is hydrolysed at a rate of approximately 8.2 U/mg. Lysosomal phospholipase A1 is a glycoprotein of about 29 kDa with an isoelectric point of pH 5.3. Unspecific extralysosomal endogenous inhibitors of this enzyme are pH range, inorganic cations, and various proteins. Divalent cations are more potent inhibitors than monovalent ones. Most endogenous intra- and extracellular proteins inhibit the enzyme, the cationic species exhibiting high inhibitory potencies, glycoproteins only little. Inhibitory proteins act through their binding to the substrate. Lysosomal phospholipase A1 seems to be an important target in drug-induced lipidosis. This lipid storage disease is caused by various cationic amphiphilic drugs that are trapped intralysosomally by protonation. In lysosomes such compounds raise the pH, interact with the polar lipids to be degraded and the lysosomal lipolytic enzymes, such as phospholipase A1. These mechanisms result in impaired intralysosomal phospholipid degradation and hence in intralysosomal phospholipid accumulation.
Similar content being viewed by others
References
Ansell GB, Spanner S (1982) Phosphatidylserine, phosphatidylethanolamine and phosphatidylcholine. In: Hawthorne JN, Ansell GB (eds) Phospholipids. Elsevier Biomedical Press, Amsterdam, New York, pp 1–49
Barenholz Y, Gatt S (1982) Sphingomyelin: metabolism, chemical synthesis, chemical and physical properties. In: Hawthorne JN, Ansell GB (eds) Phospholipids. Elsevier Biomedical Press, Amsterdam, New York, pp 129–177
Bell RM, Ballas LM, Coleman RA (1981) Lipid topogenesis. J Lipid Res 22:391–403
Dallner G (1974) Isolation of rough and smooth microsomes — general. Methods Enzymol 31 A:191–201
De Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, van Hoof F (1974) Commentary. Lysosomotropic agents. Biochem Pharmacol 23:2495–2531
De Duve C, Pressman BC, Gianetto R, Wattiaux R, Applemans F (1955) Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J 60:604–617
Fleischer B (1974) Isolation and characterization of Golgi apparatus and membranes from rat liver. Methods Enzymol 31 A:180–191
Hawthorne JN (1982) Inositol phospholipids. In: Hawthorne JN, Ansell GB (eds) Phospholipids. Elsevier Biomedical Press, Amsterdam, New York, pp 263–278
Horrocks LA, Sharma M (1982) Plasmalogens and O-alkyl glycerophospholipids. In: Hawthorne JN, Ansell GB (eds) Phospholipids. Elsevier Biomedical Press, Amsterdam, New York, pp 51–93
Hostetler Y (1982) Polyglycerophospholipids: phosphatidylglycerol, diphosphatidylglycerol and bis(monoacylglycero)phosphate. In: Hawthorne JN, Ansell GB (eds) Phospholipids. Elsevier Biomedical Press, Amsterdam, New York, pp 215–261
Hostetler KY (1984) Molecular studies of the induction of cellular phospholipidosis by cationic amphiphilic drugs. Fed Proc 43:2582–2585
Hostetler KY, Yazaki PJ, van den Bosch H (1982) Purification of lysosomal phospholipase A — evidence for multiple isoenzymes in rat liver. J Biol Chem 257:13367–13373
Kubo M, Hostetler KY (1985) Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1. Biochemistry 24:6515–6520
Kunze H, Bohn E, Löffler B-M (1988) Inhibitors of liver lysosomal acid phospholipase A1. Eur J Biochemistry (in press)
Kunze H, Hesse B, Bohn E (1982) Hydrolytic degradation of phosphatidylethanolamine and phosphatidylcholine by isolated rat-liver lysosomes. Biochim Biophys Acta 711:10–18
Kunze H, Hesse B, Bohn E (1982) Effects of antimalarial drugs on several rat-liver lysosomal enzymes involved in phosphatidylethanolamine catabolism. Biochim Biophys Acta 713:112–117
Kunze H, Hesse B, Löffler B-M (1986) Diacylglycerol hydrolysis in rat liver lysosomes. FEBS Lett 204:377–380
Löffler B-M, Bohn E, Hesse B, Kunze H (1985) Effects of antimalarial drugs on phospholipase A and lysophospholipase activities in plasma membrane, mitochondrial, microsomal and cytosolic subcellular fractions of rat liver. Biochim Biophys Acta 835:448–455
Löffler B-M, Bohn E, Kunze H (1988) Inhibition of liver lysosomal acid phospholipase A1 by blood serum proteins. Biochem Int 17:965–971
Löffler B-M, Hesse B, Kunze H (1984) A combined assay of three lysosomal marker enzymes: acid phosphatase, β-d-glucuronidase, and β-N-acetyl-d-hexosaminidase. Anal Biochem 142:312–316
Löffler B-M, Kunze H (1987) Fractionation, biochemical characterization and lysosomal phospholipases of human liver. FEBS Lett 216:51–56
Löffler B-M, Kunze H (1988) An improved purification procedure for rat liver lysosomal phospholipase A1. Biochem Int (in press)
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Lüllmann H, Lüllmann-Rauch R, Wassermann O (1975) Drug-induced phospholipidosis. Crit Rev Toxicol 4:185–218
Lüllmann H, Lüllmann-Rauch R, Wassermann O (1978) Commentary. Lipidosis induced by amphiphilic cationic drugs. Biochem Pharmacol 27:1103–1108
Lüllmann H, Wehling M (1979) The binding of drugs to different polar lipids in vitro. Biochem Pharmacol 28:3409–3415
Lüllmann-Rauch R (1979) Drug-induced lysosomal storage disorders. Lysosomes Appl Biol Ther 6:49–130
Matsuzawa Y, Hostetler KY (1980) Properties of phospholipase C isolated from rat liver lysosomes. J Biol Chem 255:646–652
Robinson M, Waite M (1983) Physical-chemical requirements for the catalysis of substrates by lysosomal phospholipase A1. J Biol Chem 258:14371–14378
Schmidt M, Löffler B-M, Kunze H (1986) Acid phospholipase A1 (EC 3. 1. 1. 32) activity in rat liver Golgi vesicles. Biol Chem Hoppe-Seyler [Suppl 367]:333
Seydel JK, Wassermann O (1976) NMR studies on the molecular basis of drug-induced phospholipidosis. II. Interaction between several amphiphilic drugs and phospholipids. Biochem Pharmacol 25:2357–2364
Van den Bosch H (1980) Intracellular phospholipases. Biochim Biophys Acta 604:191–246
Van den Bosch H (1982) Phospholipases. In: Hawthorne JN, Ansell GB (eds), Phospholipids. Elsevier Biomedical Press, Amsterdam, New York, pp 313–357
Van den Bosch H, van Golde LMG, van Deenen LLM (1972) Dynamics of phosphoglycerides. Rev Physiol Biochem Exp Pharmacol 66:13–145
Wattiaux R, Wattiaux-De Conninck S, Ronveaux-Dupal M-F, Dubois F (1978) Isolation of rat liver lysosomes by isopycnic centrifugation in a metrizamide gradient. J Cell Biol 78:349–368
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Walther Vogt on the occasion of his 70th birthday
Rights and permissions
About this article
Cite this article
Kunze, H., Löffler, B.M. Acid phospholipase A1 in liver — A brief survey. Klin Wochenschr 67, 126–130 (1989). https://doi.org/10.1007/BF01711337
Issue Date:
DOI: https://doi.org/10.1007/BF01711337